[go: up one dir, main page]

TNSN92117A1 - Sels stables d'acide (+) (-1s,2r) -2 [n-2-hydroxylamino-2- oxoethyl] -n-methyl-amino] carbonyl] cyclohexane -1- carboxylique, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Sels stables d'acide (+) (-1s,2r) -2 [n-2-hydroxylamino-2- oxoethyl] -n-methyl-amino] carbonyl] cyclohexane -1- carboxylique, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
TNSN92117A1
TNSN92117A1 TNTNSN92117A TNSN92117A TNSN92117A1 TN SN92117 A1 TNSN92117 A1 TN SN92117A1 TN TNSN92117 A TNTNSN92117 A TN TNSN92117A TN SN92117 A TNSN92117 A TN SN92117A TN SN92117 A1 TNSN92117 A1 TN SN92117A1
Authority
TN
Tunisia
Prior art keywords
hydroxylamino
oxoethyl
cyclohexane
carbonyl
carboxylic
Prior art date
Application number
TNTNSN92117A
Other languages
English (en)
Inventor
Raffaello Giorgi
Alessandro Subissi
Luigi Turbanti
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Publication of TNSN92117A1 publication Critical patent/TNSN92117A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LES NOUVEAUX SELS DE L'ACIDE (+) -(1S,2R)-2-[[N-(2- HYDROXYLAMINO-2-OXOETHYL) N-METHYLAMINO] CARBONYL] CYCLOHEXANE-1- CARBOXYLIQUE AVEC DES METAUX ET BASES ORGANIQUES REPRESENTE PAR LA FORMULE GENERALE (I) OU R ET R', S'ILS SONT PRIS ENSEMBLE, REPRESENTENT UN CATION BIVALENT CHOISI PARMI LE CALCIUM, L'ETHYLENE DIAMINO ET AUTRES CATIONS PHARMACEUTIQUEMENT ACCEPTABLES OU BASES ORGANIQUES, OU BIEN SI R' = H+, R REPRESENTE LE SODIUM, LE POTASSIUM, UN GROUPE IMIDAZOLE, LA LYSINE, LA CHOLINE, LA DIETHANOLAMINE, L'ARGININE OU L'HISTIDINE, POSSEDENT UNE ACTIVITE D'INHIBITION DE ACE ET SONT PAR CONSEQUENT UTILES COMME INGREDIENTS ACTIFS DE MEDICAMENTS CONTRE L'HYPERTENSION. LE PROCEDE POUR LEUR PREPARATION COMPORTE DE PREFERENCE LA REACTION DE L'ACIDE DE DEPART, PROTEGE PAR UN GROUPE BENZYLE, AVEC L'HYDRATE, CARBONATE OU BASE ORGANIQUE APPROPRIE EN CONDITIONS D'HYDROGENATION EN PRESENCE D'UN CATALYSEUR D'HYDROGENATION
TNTNSN92117A 1991-12-23 1992-12-23 Sels stables d'acide (+) (-1s,2r) -2 [n-2-hydroxylamino-2- oxoethyl] -n-methyl-amino] carbonyl] cyclohexane -1- carboxylique, procede pour leur preparation et compositions pharmaceutiques les contenant TNSN92117A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Publications (1)

Publication Number Publication Date
TNSN92117A1 true TNSN92117A1 (fr) 1993-06-08

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN92117A TNSN92117A1 (fr) 1991-12-23 1992-12-23 Sels stables d'acide (+) (-1s,2r) -2 [n-2-hydroxylamino-2- oxoethyl] -n-methyl-amino] carbonyl] cyclohexane -1- carboxylique, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (26)

Country Link
EP (1) EP0575572A1 (fr)
JP (1) JPH06506002A (fr)
CN (1) CN1079474A (fr)
AU (1) AU657591B2 (fr)
BG (1) BG98050A (fr)
BR (1) BR9205652A (fr)
CA (1) CA2104372A1 (fr)
CZ (1) CZ379692A3 (fr)
EE (1) EE9400006A (fr)
FI (1) FI933685A0 (fr)
HR (1) HRP921454A2 (fr)
HU (1) HUT69287A (fr)
IT (1) IT1252708B (fr)
LV (1) LV10426B (fr)
MA (1) MA22749A1 (fr)
MX (1) MX9207543A (fr)
NZ (1) NZ245547A (fr)
PL (1) PL169086B1 (fr)
PT (1) PT101156A (fr)
RU (1) RU2079489C1 (fr)
SI (1) SI9200409A (fr)
SK (1) SK379692A3 (fr)
TN (1) TNSN92117A1 (fr)
WO (1) WO1993013056A1 (fr)
YU (1) YU110892A (fr)
ZA (1) ZA9210004B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
CN101516191A (zh) * 2006-09-28 2009-08-26 默克公司 Saha的胺碱盐和其多晶型物
AU2021263319B2 (en) * 2020-04-27 2022-12-01 Carter-Hoffmann, Llc Door movement system for cabinet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
PL169086B1 (pl) 1996-05-31
MX9207543A (es) 1993-08-01
PL297118A1 (en) 1993-09-06
HU9302389D0 (en) 1993-11-29
LV10426B (en) 1995-08-20
YU110892A (sh) 1996-01-08
FI933685A7 (fi) 1993-08-20
FI933685L (fi) 1993-08-20
CZ379692A3 (en) 1993-09-15
ITMI913448A1 (it) 1993-06-23
LV10426A (lv) 1995-02-20
CA2104372A1 (fr) 1993-06-24
NZ245547A (en) 1995-12-21
WO1993013056A1 (fr) 1993-07-08
EE9400006A (et) 1995-12-15
ZA9210004B (en) 1993-12-13
HRP921454A2 (en) 1995-02-28
BG98050A (bg) 1994-04-29
EP0575572A1 (fr) 1993-12-29
MA22749A1 (fr) 1993-07-01
AU657591B2 (en) 1995-03-16
AU3087192A (en) 1993-07-28
HUT69287A (en) 1995-09-28
IT1252708B (it) 1995-06-26
FI933685A0 (fi) 1993-08-20
SI9200409A (en) 1993-09-30
PT101156A (pt) 1994-06-30
JPH06506002A (ja) 1994-07-07
RU2079489C1 (ru) 1997-05-20
SK379692A3 (en) 1995-04-12
CN1079474A (zh) 1993-12-15
ITMI913448A0 (it) 1991-12-23
BR9205652A (pt) 1994-05-03

Similar Documents

Publication Publication Date Title
ES2345100T3 (es) Compuestos que tienen actividad inhibidora reversible de carnitina palmitoiltransferasa.
US4413141A (en) 2-(Difluoromethyl)-2,5-diaminopentanoic acid
US20150250786A1 (en) Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
TNSN05250A1 (fr) Pyrimidinones substituees
CN102216257A (zh) Gaba偶联物及其使用方法
RU95108332A (ru) Производные индола и их таутомерные формы, смеси их изомеров и фармацевтическая композиция с антиопухолевой или ингибирующей протеин-тирозин-киназы активностью и способ торможения зависящего от протеин-тирозин-киназы заболевания или борьбы с аберрантным ростом клеток млекопитающего или человека
BR9810841A (pt) Inibidores de metaloprotease alicìclicos
CA2451569A1 (fr) Inhibiteurs hydrazino carbocycliques des amine oxydases a teneur en cuivre
DE69832268T2 (de) Peptidyl2-amino-1hydroxyalkansulfonsäuren als zysteinprotease-inhibitoren
TNSN04212A1 (fr) Sels de tolterodine
JPWO2002076935A1 (ja) 新規α−リポ酸誘導体およびその用途
Baker et al. Nonclassical Antimetabolites. X. 1, 2 A Facile Synthesis of 4-Quinazolone-2-carboxylic acid and the structure of bogert's ammonium salt
EP0487620A1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique.
EP0068998B1 (fr) Aryl-1 aminométhyl-2 cyclopropanes carboxylates (Z), leur préparation et leur application en tant que médicaments utiles dans le traitement d'algies diverses
US5840979A (en) Aliphatic propargylamines as cellular rescue agents
TNSN92117A1 (fr) Sels stables d'acide (+) (-1s,2r) -2 [n-2-hydroxylamino-2- oxoethyl] -n-methyl-amino] carbonyl] cyclohexane -1- carboxylique, procede pour leur preparation et compositions pharmaceutiques les contenant
US4389415A (en) Method of treating hypertension
AU599567B2 (en) Method of treating memory disorders of the elderly
EP0485583A1 (fr) Utilisation de derives de la tetrahydro isoquinoleine pour la preparation de medicaments anti-tumoraux.
GB2120244A (en) Aminoalkadiene derivative
CS209857B2 (en) Method of making the new derivatives of the aminoacids
BG100716A (bg) Подобряване на поносимостта на фармацевтично активни бета-аминокиселини
AU598721B2 (en) Method of lowering blood sugar level in vertebrates
US6469064B2 (en) Materials and methods for the treatment of depression
Buu et al. Biological actions in vivo and in vitro of two γ-aminobutyric acid (GABA) analogues: β-chloro GABA and β-phenyl GABA